Amedisys Cash on Hand 2010-2025 | AMED
Amedisys cash on hand from 2010 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Amedisys Annual Cash on Hand
(Millions of US $) |
| 2024 |
$303 |
| 2023 |
$139 |
| 2022 |
$54 |
| 2021 |
$46 |
| 2020 |
$83 |
| 2019 |
$96 |
| 2018 |
$20 |
| 2017 |
$86 |
| 2016 |
$30 |
| 2015 |
$28 |
| 2014 |
$8 |
| 2013 |
$17 |
| 2012 |
$15 |
| 2011 |
$48 |
| 2010 |
$120 |
| 2009 |
$34 |
Amedisys Quarterly Cash on Hand
(Millions of US $) |
| 2025-03-31 |
$285 |
| 2024-12-31 |
$303 |
| 2024-09-30 |
$245 |
| 2024-06-30 |
$157 |
| 2024-03-31 |
$121 |
| 2023-12-31 |
$139 |
| 2023-09-30 |
$94 |
| 2023-06-30 |
$111 |
| 2023-03-31 |
$69 |
| 2022-12-31 |
$54 |
| 2022-09-30 |
$31 |
| 2022-06-30 |
$49 |
| 2022-03-31 |
$71 |
| 2021-12-31 |
$46 |
| 2021-09-30 |
$128 |
| 2021-06-30 |
$93 |
| 2021-03-31 |
$78 |
| 2020-12-31 |
$83 |
| 2020-09-30 |
$115 |
| 2020-06-30 |
$180 |
| 2020-03-31 |
$178 |
| 2019-12-31 |
$96 |
| 2019-09-30 |
$21 |
| 2019-06-30 |
$14 |
| 2019-03-31 |
$11 |
| 2018-12-31 |
$20 |
| 2018-09-30 |
$14 |
| 2018-06-30 |
$26 |
| 2018-03-31 |
$120 |
| 2017-12-31 |
$86 |
| 2017-09-30 |
$66 |
| 2017-06-30 |
$59 |
| 2017-03-31 |
$48 |
| 2016-12-31 |
$30 |
| 2016-09-30 |
$9 |
| 2016-06-30 |
$10 |
| 2016-03-31 |
$8 |
| 2015-12-31 |
$28 |
| 2015-09-30 |
$57 |
| 2015-06-30 |
$33 |
| 2015-03-31 |
$3 |
| 2014-12-31 |
$8 |
| 2014-09-30 |
$6 |
| 2014-06-30 |
$11 |
| 2014-03-31 |
$3 |
| 2013-12-31 |
$17 |
| 2013-09-30 |
$44 |
| 2013-06-30 |
$30 |
| 2013-03-31 |
$7 |
| 2012-12-31 |
$15 |
| 2012-09-30 |
$39 |
| 2012-06-30 |
$37 |
| 2012-03-31 |
$41 |
| 2011-12-31 |
$48 |
| 2011-09-30 |
$29 |
| 2011-06-30 |
$28 |
| 2011-03-31 |
$149 |
| 2010-12-31 |
$120 |
| 2010-09-30 |
$128 |
| 2010-06-30 |
$116 |
| 2010-03-31 |
$82 |
| 2009-12-31 |
$34 |
| 2009-09-30 |
$45 |
| 2009-06-30 |
$1 |
| 2009-03-31 |
$26 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$3.105B |
$2.348B |
|
Amedisys Inc. provides home health and hospice services throughout the U.S. to the growing chronic, co-morbid, and aging American population. The company also offers clinically focused programs for chronic conditions and various diseases such as diabetes, coronary artery disease, congestive heart failure, orthopedics, complex wound care, geriatric surgical recovery, balance retraining, behavioral health and stroke recovery, as well as various rehabilitative programs. It provides hospice services to patients using an interdisciplinary care team comprising a physician, nurses, home health aides, social workers, therapists, dieticians, volunteers, counselors, chaplains and bereavement coordinators, when required. The company depends on reimbursement from Medicare (for chronic care) for a significant portion of its revenues on account of the age demographics of its patient base (average age of 81).
|
